- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-GOLPH3
GOLPH3 Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IF/ICC, IP, CoIP, ELISA
Conjugaison
Non conjugué
N° de cat : 19112-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HeLa, tissu pulmonaire de souris, tissu testiculaire de rat, tissu testiculaire de souris |
| Résultats positifs en IP | tissu testiculaire de souris |
| Résultats positifs en IHC | tissu de cancer du côlon humain, tissu de côlon humain, tissu placentaire humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
| Résultats positifs en IF/ICC | cellules HepG2, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochimie (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 10 publications below |
| WB | See 19 publications below |
| IHC | See 11 publications below |
| IF | See 6 publications below |
| IP | See 2 publications below |
| CoIP | See 1 publications below |
Informations sur le produit
19112-1-AP cible GOLPH3 dans les applications de WB, IHC, IF/ICC, IP, CoIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Réactivité citée | Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | GOLPH3 Protéine recombinante Ag5443 |
| Nom complet | golgi phosphoprotein 3 (coat-protein) |
| Masse moléculaire calculée | 298 aa, 34 kDa |
| Poids moléculaire observé | 34 kDa |
| Numéro d’acquisition GenBank | BC033725 |
| Symbole du gène | GOLPH3 |
| Identification du gène (NCBI) | 64083 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
GOLPH3 (also called GPP34, GMx33, MIDAS, or yeast Vps74p) is a 34-kDa Golgi-associated protein conserved from yeast to human. GOLPH3 binds to PtdIns(4)P-rich trans-Golgi membranes and MYO18A conveying a tensile force required for efficient tubule and vesicle formation (PMID: 19837035). GOLPH3 has been recently demonstrated as a novel oncoprotein amplified in various types of human malignancies, including melanoma, breast, non-small cell lung cancer, gliomas and connective tissue tumors (PMID:19553991; 23006319; 21499727; 22745132). Enhanced activation of mTOR signalling represents a molecular basis for the oncogenic activity of GOLPH3 (PMID: 19553991).
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for GOLPH3 antibody 19112-1-AP | Download protocol |
| IHC protocol for GOLPH3 antibody 19112-1-AP | Download protocol |
| IF protocol for GOLPH3 antibody 19112-1-AP | Download protocol |
| IP protocol for GOLPH3 antibody 19112-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Theranostics miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness.
| ||
Cancer Res A Novel Micropeptide Encoded by Y-Linked LINC00278 Links Cigarette Smoking and AR Signaling in Male Esophageal Squamous Cell Carcinoma. | ||
Cell Death Dis GOLPH3/CKAP4 promotes metastasis and tumorigenicity by enhancing the secretion of exosomal WNT3A in non-small-cell lung cancer | ||
Front Oncol FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer. | ||
Br J Cancer GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma. | ||
J Exp Clin Cancer Res STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer. |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH Boyan (Verified Customer) (04-17-2023) | fairly good for IF, but not as clear as the images in its booklet
|











